BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1718023)

  • 21. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
    Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
    Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse low-density areas in white matter on CT scans after intracarotid ACNU infusion--report of three cases.
    Sako K; Yonemasu Y; Okazaki S; Hodozuka A; Fujita T; Daita G; Takei H
    Neurol Med Chir (Tokyo); 1990 Sep; 30(9):685-90. PubMed ID: 1708459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
    Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
    Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma.
    Vance RB; Kapp JP
    J Neurooncol; 1986; 3(4):287-90. PubMed ID: 3958775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I study of intracarotid artery infusion of cis-Diamminedichloroplatinum(II) in patients with recurrent malignant intracerebral tumors.
    Stewart DJ; Wallace S; Feun L; Leavens M; Young SE; Handel S; Mavligit G; Benjamin RS
    Cancer Res; 1982 May; 42(5):2059-62. PubMed ID: 7199971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
    Kapp JP; Sanford RA
    Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capillary permeability in experimental rat glioma and effects of intracarotid CDDP administration on tumor drug delivery.
    Ichimura K; Ohno K; Aoyagi M; Tamaki M; Suzuki R; Hirakawa K
    J Neurooncol; 1993 Jun; 16(3):211-5. PubMed ID: 8301345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors.
    Madajewicz S; Chowhan N; Iliya A; Roque C; Beaton R; Davis R; Fertman S; Meek A; Alvarez O; Pampati M
    Cancer; 1991 Jun; 67(11):2844-9. PubMed ID: 1851050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
    Bobo H; Kapp JP; Vance R
    J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study.
    Follézou JY; Fauchon F; Chiras J
    Neoplasma; 1989; 36(3):349-52. PubMed ID: 2544815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report.
    Nakagawa H; Fujita T; Kubo S; Tsuruzono K; Yamada M; Tokiyoshi K; Miyawaki Y; Kanayama T; Kadota T; Hayakawa T
    Surg Neurol; 1994 Jan; 41(1):19-27. PubMed ID: 8310382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration].
    Nakagawa H; Fujita T; Izumoto S; Kubo S; Nakajima Y; Turuzono K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):103-9. PubMed ID: 1987891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
    Stewart DJ; Grahovac Z; Hugenholtz H; DaSilva V; Richard MT; Benoit B; Belanger G; Russell N
    J Neurooncol; 1993 Jul; 17(1):71-9. PubMed ID: 8120574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.
    Miller DF; Bay JW; Lederman RJ; Purvis JD; Rogers LR; Tomsak RL
    Ophthalmology; 1985 Mar; 92(3):402-6. PubMed ID: 2986069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
    Inamura T; Nomura T; Bartus RT; Black KL
    J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
    Hurwitz CA; Strauss LC; Kepner J; Kretschmar C; Harris MB; Friedman H; Kun L; Kadota R
    J Pediatr Hematol Oncol; 2001; 23(5):277-81. PubMed ID: 11464982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
    Kapp JP; Vance RB
    J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.